Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 143Leukemia 135Leukemia, Myeloid, Acute 117Lymphoma 83Burkitt Lymphoma 68Lymphoma, Non-Hodgkin 65Lymphoma, Large B-Cell, Diffuse 63Leukemia, Lymphocytic, Chronic, B-Cell 56Lymphoma, Follicular 55Lymphoma, Large-Cell, Immunoblastic 52Lymphoma, Mantle-Cell 49Congenital Abnormalities 43Lymphoma, B-Cell, Marginal Zone 42Myelodysplastic Syndromes 35Hodgkin Disease 35Leukemia, Myelomonocytic, Acute 32Leukemia, Monocytic, Acute 31Leukemia, Erythroblastic, Acute 31Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 29Leukemia, Megakaryoblastic, Acute 29Multiple Myeloma 25Blast Crisis 22Waldenstrom Macroglobulinemia 21Recurrence 21Myeloproliferative Disorders 21Leukemia, Myeloid, Chronic-Phase 20Leukemia, Myeloid, Accelerated Phase 20Dendritic Cell Sarcoma, Interdigitating 19Lymphoma, T-Cell, Cutaneous 18Leukemia, Myelomonocytic, Chronic 18

Interventions

Imatinib Mesylate 14Dasatinib 5nilotinib 4bosutinib 4Cyclophosphamide 4fludarabine 3Vincristine 3Methotrexate 3Dexamethasone 3Cytarabine 3peginterferon alfa-2a 2fludarabine phosphate 2asciminib 2Prednisone 2Daunorubicin 2Azacitidine 2Acetaminophen 24-methyl-N-(3-(4-methylimidazol-1-yl)-5-trifluoromethylphenyl)-3-(4-pyrazin-2-ylpyrimidin-2-ylamino)benzamide 2venetoclax 1thymoglobulin 1ponatinib 1olverembatinib 1flumatinib 1blinatumomab 1Whole-Body Irradiation 1Tyrosine Kinase Inhibitors 1Tacrolimus 1Rituximab 1Prednisolone 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Philadelphia Chromosome × Etoposide × Other hematologic neoplasm × Clear all
NCT02523976 2026-02-11

Dasatinib Combined With Chemotherapy in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Institute of Hematology & Blood Diseases Hospital, China

Phase 2 Completed
30 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Philadelphia Chromosome, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡